Lucentis and Ventolin hfa drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lucentis (ranibizumab) and Ventolin hfa (albuterol sulfate). Common drug interactions include eye pruritus among females and drug ineffective among males.

The phase IV clinical study analyzes what interactions people have when they take Lucentis and Ventolin hfa. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Lucentis?

Lucentis has active ingredients of ranibizumab. It is often used in macular degeneration. eHealthMe is studying from 25,647 Lucentis users. Check the latest studies of Lucentis.

What is Ventolin hfa?

Ventolin hfa has active ingredients of albuterol sulfate. It is often used in asthma. eHealthMe is studying from 40,061 Ventolin hfa users. Check the latest studies of Ventolin hfa.



On Jul, 08, 2026

15 people who take Lucentis and Ventolin hfa together, and have interactions are studied.

Lucentis and Ventolin hfa drug interactions.

What are the common drug interactions of Lucentis and Ventolin Hfa, by gender? *:

female:

  1. Eye pruritus (eye itching)
  2. Fatigue (feeling of tiredness)
  3. Feeling jittery
  4. Foreign body sensation in eyes (feeling of something in eye)
  5. Heart rate increased
  6. Insomnia (sleeplessness)
  7. Irritability
  8. Myalgia (muscle pain)
  9. Nervousness
  10. Nocturnal dyspnoea (attacks of severe shortness of breath and coughing that generally occur at night)

male:

  1. Drug ineffective
  2. Injection site pain

What are the common drug interactions of Lucentis and Ventolin Hfa, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Abdominal pain upper
  2. Asthenia (weakness)
  3. Nocturnal dyspnoea (attacks of severe shortness of breath and coughing that generally occur at night)
  4. Sensory disturbance (sense disturbance)
  5. Tremor (trembling or shaking movements in one or more parts of your body)
  6. Vision blurred
  7. Body temperature decreased
  8. Fatigue (feeling of tiredness)
  9. Feeling jittery
  10. Heart rate increased

What are the existing conditions these people have? *

  1. Retinal Vessel Occlusion (a blockage in one of the small arteries): 4 people, 26.67%
  2. Diabetic Retinopathy (damage to the retina caused by complications of diabetes): 3 people, 20.00%
  3. Macular Oedema (fluid and protein deposits collect on or under the macula of the eye (a yellow central area of the retina) and causes it to thicken): 2 people, 13.33%
  4. Choroidal Neovascularisation (creation of new blood vessels in vascular layer of eye): 2 people, 13.33%
  5. Type 2 Diabetes: 1 person, 6.67%
  6. Type 1 Diabetes: 1 person, 6.67%
  7. Sleep Disorder: 1 person, 6.67%
  8. Fibromyalgia (a long-term condition which causes pain all over the body): 1 person, 6.67%
  9. Dyspnea (difficult or laboured breathing): 1 person, 6.67%
  10. Diabetes: 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Lucentis and Ventolin hfa?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Lucentis and Ventolin hfa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lucentis:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ventolin hfa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lucentis and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ventolin hfa and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ranibizumab and albuterol sulfate (the active ingredients of Lucentis and Ventolin hfa, respectively), and Lucentis and Ventolin hfa (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: